DNA analysis system
AssigneeHitachi, Ltd.
InventorsAtsumu Hirabayashi, Min Huang, Yukiko Hirabayashi, Akihiko Okumura
Life of this patent
Estimating the term…
Loading patent…
AssigneeHitachi, Ltd.
InventorsAtsumu Hirabayashi, Min Huang, Yukiko Hirabayashi, Akihiko Okumura
Estimating the term…
A genome DNA analysis method and a genome DNA analysis system of the present invention generates multiply-charged ions with 5 or more electric charges by an ionization process using air atomization. Also, a mass spectrometric spectrum thereof is detected and compared with predicted mass spectrum patterns in the presence or absence of polymorphism to determine a base at a polymorphic point.
A DNA analysis method for analyzing DNA polymorphism, comprising the steps of:
A DNA analysis method for analyzing DNA polymorphism, comprising the steps of:
A DNA analysis method for analyzing DNA polymorphism, comprising the steps of:
A DNA analysis method for analyzing DNA polymorphism, comprising:
A DNA analysis method for analyzing DNA polymorphism, comprising the steps of:
Dependencies are inferred from the claim text.
Drawings are temporarily unavailable. Open the PDF at USPTO
From the US filing history. Foreign family members aren’t listed.
Details: ion sources; Ion guns
Hybridisation assays: for detection of mutation or polymorphism
Methods for sequencing: involving mass spectrometry
Electric discharge tubes or discharge lamps
Term ended 30 Aug 2021 (estimated)
1. Field of the Invention
The present invention relates to measurements on biological materials, which require a high throughput. Specifically, the present invention relates to a method and system for analyzing DNA-polymorphisms in the human genome, such as single nucleotide polymorphisms (SNPs) that are single-base variations at a unique physical location among different individuals.
2. Description of the Prior Art
The above and other objects, features and advantages of the present invention will be apparent from the following detailed description of the preferred embodiments of the invention in conjunction with the accompanying drawings, in which:
FIG. 1 is a schematic diagram that illustrates a genome DNA analysis system as a first embodiment of the present invention;
FIG. 2 is a graphical representation that illustrates charts of mass spectra of outputs I(i), S(i), S(i−1), and S(i−2);
Preferred embodiments of the present invention will now be described with reference to the accompanying drawings.
[First Embodiment]
FIG. 1 is a schematic diagram that illustrates a genome DNA analysis system as one of preferred embodiments of the present invention. The genome DNA analysis system mainly includes three structural assemblies: a sample-preparation system, a measurement system, and a control system. The sample preparation system includes a sample treatment part 11 for preparing a sample, a container 12 in which a cleaning fluid is filled, a pump 14, and a sampling part 15. A sample prepared by the sample preparation system is transferred to the measurement system through the sampling part 15. The measurement system includes an ionization part 21 having a gas-supply part 22, and a mass spectrometric part 24 that carries out an analysis of multiply-charged ions 23 generated from the ionization part 21. Furthermore, the control system includes: an output prediction part 32 that predicts the results to be obtained from the analysis based on the sample information transmitted from the sample treatment part 11; an output analysis part 35 that analyzes an output from the mass spectrometric part 24 of the measurement system; a data analysis part 33 that generates the results of the sample analysis by performing a comparison between a predicted output from the output prediction part 32 and an actual output from the output analysis part 35; a recording part 34 that makes a record of the analyzing results from the data analysis part 33; and a control part 31 that controls the sampling part 15 of the sample preparation system and the output analysis part 35. Furthermore, as shown in FIG. 1, a display part 41 may be provided on the genome DNA analysis system. The display part 41 displays any information on its screen. The information includes the current analyzing status of the system (i.e., the information for defining whether the system functions normally or abnormally) and the latest analyzing results that include a mass spectrum.